Yüklüyor......
Generation of Recombinant SARS‐CoV‐2 Using a Bacterial Artificial Chromosome
SARS‐CoV‐2, the causative agent of COVID‐19, has been responsible for a million deaths worldwide as of September 2020. At the time of this writing, there are no available US FDA−approved therapeutics for the treatment of SARS‐CoV‐2 infection. Here, we describe a detailed protocol to generate recombi...
Kaydedildi:
| Yayımlandı: | Curr Protoc Microbiol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646048/ https://ncbi.nlm.nih.gov/pubmed/33048448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpmc.126 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|